{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:48:15Z","timestamp":1790952495465,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":5084,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1093\/annonc\/mdj037","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T01:13:22Z","timestamp":1131671602000},"page":"141-145","source":"Crossref","is-referenced-by-count":30,"title":["Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity"],"prefix":"10.1016","volume":"17","author":[{"given":"D.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bosq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Audouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chasle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Mandard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Marnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Henry-Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj037_bb0010","series-title":"(eds).Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours Pathology and Genetics","author":"Jaffe","year":"2001"},{"key":"10.1093\/annonc\/mdj037_bb0015","first-page":"1294","article-title":"Follicular Hodgkin's disease","volume":"19","author":"Ashton-Key","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdj037_bb0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European task force on lymphoma project on lymphocyte predominant Hodgkin's disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj037_bb0025","first-page":"1889","article-title":"European task force on lymphoma project on lymphocyte predominant Hodgkin's disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdj037_bb0030","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/annonc\/5.suppl_2.S107","article-title":"Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early stage Hodgkin's disease","volume":"5","author":"Noordijk","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj037_bb0035","doi-asserted-by":"crossref","unstructured":"Ferm\u00e9 C, Eghbali H, Hagenbeek A et al. MOPP\/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I\u2013II Hodgkin's disease: Comparison of three treatment modalities. Preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients. Proceedings of the 42nd Annual Meeting of the American Society of Hematology, San Francisco, CA, 1\u20135 December 2000. Blood 2000; 96: 576a.","DOI":"10.1016\/S1526-9655(11)70167-1"},{"key":"10.1093\/annonc\/mdj037_bb0040","first-page":"575a","volume":"96","author":"Hagenbeek","year":"2000","journal-title":"Proceedings of the 42nd Annual Meeting of the American Society of Hematology San Francisco CA 15 December 2000 Blood"},{"key":"10.1093\/annonc\/mdj037_bb0045","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa022628","article-title":"Involved-field radiotherapy for advanced Hodgkin's lymphoma","volume":"348","author":"Aleman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdj037_bb0050","series-title":"Epidemiologic Analysis with a Programmable Calculator","author":"Rothman","year":"1982"},{"key":"10.1093\/annonc\/mdj037_bb0055","series-title":"Release 7.0","author":"StataCorp. Stata Statistical Software","year":"2001"},{"key":"10.1093\/annonc\/mdj037_bb0060","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2002-05-1548","article-title":"Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages","volume":"101","author":"Von Wasielewski","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdj037_bb0065","first-page":"1755","article-title":"Criteria for involvement of lymph node, bone marrow spleen and liver in Hodgkin's disease","volume":"31","author":"Lukes","year":"1971","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj037_bb0070","first-page":"1644","article-title":"Typing the histiogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte predominance Hodgkin's lymphoma","volume":"63","author":"Brauninger","year":"2003","journal-title":"Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/1\/141\/380521\/mdj037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T18:20:13Z","timestamp":1635790813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419403438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0923753419403438"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj037","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}